Dept of endocrinology , Herlev Hospital
Herlev, dk-3650, Denmark
NCT Number: NCT00531713
To compare the effect of T4-T3 combination therapy versus T4 monotherapy in patients with autoimmune hypothyroidism, on stable T4-substitution therapy
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
Herlev, dk-3650, Denmark
double blind randomized cross-over study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50 microgram of the usual T4 is withdrawn and the patients is given 20 microgram of T3
Time frame: 3 month treating
Time frame: 3 month treament
Copenhagen University Hospital at Herlev
Other
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.
Acronym: T4-T3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07681037
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Merkez, Edirne, Turkey (Türkiye)
View Trial DetailsNCT07649187
Activities of Daily Living, Autoimmune Diseases
Taipei, Taiwan
View Trial DetailsNCT06791967
Behavior, Behavioral Symptoms
Taipei, Taiwan
View Trial DetailsNCT07454213
Activities of Daily Living, Behavior
Istanbul, Turkey (Türkiye)
View Trial Details